Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic alterations in acute myeloid leukemias
Parinaz Mehdipour, Fabio Santoro, Saverio Minucci
FEBS Journal (2014) Vol. 282, Iss. 9, pp. 1786-1800
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Céline Berthon, Emmanuel Raffoux, Xavier Thomas, et al.
The Lancet Haematology (2016) Vol. 3, Iss. 4, pp. e186-e195
Closed Access | Times Cited: 398
Epigenetic treatment of solid tumours: a review of clinical trials
Clara Nervi, Elisabetta De Marinis, Giovanni Codacci-Pisanelli
Clinical Epigenetics (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 195
A Comprehensive Review of Lysine-Specific Demethylase 1 and its Roles in Cancer
Amir Hosseini, Saverio Minucci
Epigenomics (2017) Vol. 9, Iss. 8, pp. 1123-1142
Closed Access | Times Cited: 127
De novodominantASXL3mutations alter H2A deubiquitination and transcription in Bainbridge–Ropers syndrome
Anshika Srivastava, K.C. Ritesh, Yao-Chang Tsan, et al.
Human Molecular Genetics (2015) Vol. 25, Iss. 3, pp. 597-608
Open Access | Times Cited: 64
Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid
Stella Pesakhov, Matan Nachliely, Zeev Barvish, et al.
Oncotarget (2016) Vol. 7, Iss. 22, pp. 31847-31861
Open Access | Times Cited: 57
Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine
Masaru Katoh
Expert Review of Proteomics (2015) Vol. 12, Iss. 3, pp. 317-328
Closed Access | Times Cited: 53
CDK6 Inhibition: A Novel Approach in AML Management
Iris Z. Uras, Veronika Sexl, Karoline Kollmann
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2528-2528
Open Access | Times Cited: 40
Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis
Anna Eriksson, Andreas Lennartsson, Sören Lehmann
Experimental Hematology (2015) Vol. 43, Iss. 8, pp. 609-624
Open Access | Times Cited: 48
The clinical observation of none-promyelocytic AML patients inducted with idarubicin or daunorubicin included standard regimens: a tertiary care center experience
Jianhui Xu, Chaoyang Song, Yanjie He, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Touch, act and go: landing and operating on nucleosomes
Valentina Speranzini, Simona Pilotto, Titia K. Sixma, et al.
The EMBO Journal (2016) Vol. 35, Iss. 4, pp. 376-388
Open Access | Times Cited: 27
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients
Xuejie Jiang, Zhixiang Wang, Bingjie Ding, et al.
Oncotarget (2015) Vol. 6, Iss. 32, pp. 33612-33622
Open Access | Times Cited: 27
ASXL1mutations in AML are associated with specific clinical and cytogenetic characteristics
Katerina Kakosaiou, Fotios Panitsas, Aggeliki Daraki, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2018) Vol. 59, Iss. 10, pp. 2439-2446
Closed Access | Times Cited: 26
Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemia.
Harsh Goel, Ekta Rahul, Ishan Gupta, et al.
PubMed (2021) Vol. 11, Iss. 5, pp. 472-497
Closed Access | Times Cited: 18
Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients
Xiaoqing Yuan, Dao-Yu Zhang, Yan Han, et al.
Oncotarget (2016) Vol. 7, Iss. 37, pp. 60555-60574
Open Access | Times Cited: 21
Antisenescence Effect of REAC Biomodulation to Counteract the Evolution of Myelodysplastic Syndrome
Margherita Maioli, Salvatore Rinaldi, Sara Cruciani, et al.
Physiological Research (2022) Vol. 71, Iss. 4, pp. 539-549
Open Access | Times Cited: 12
Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis
Ana Cristina Gonçalves, Raquel Alves, Inês Baldeiras, et al.
Molecular Carcinogenesis (2016) Vol. 56, Iss. 1, pp. 130-148
Closed Access | Times Cited: 18
STAT3 signaling pathway is involved in decitabine induced biological phenotype regulation of acute myeloid leukemia cells.
Zhichao Zhu, Xuzhang Lu, Lijia Jiang, et al.
PubMed (2015) Vol. 7, Iss. 10, pp. 1896-907
Closed Access | Times Cited: 18
Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies
Rohit Singh, J.M. Williams, Robert Vince
European Journal of Medicinal Chemistry (2017) Vol. 139, pp. 325-336
Closed Access | Times Cited: 18
Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells
Hui Hui, Xiaoxiao Zhang, Hui Li, et al.
Journal of Cancer Research and Clinical Oncology (2016) Vol. 142, Iss. 7, pp. 1449-1459
Closed Access | Times Cited: 16
Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives
Ugo Chianese, Chiara Papulino, Wout Megchelenbrink, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 84-101
Open Access | Times Cited: 5
CircPLXNB2 regulates acute myeloid leukemia progression through miR-654-3p/ CCND1 axis
Jiao Wang, Cuiping Wu, Weilun Zhou
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 5
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
Jarmo Ritari, Kati Hyvärinen, Satu Koskela, et al.
Leukemia (2018) Vol. 33, Iss. 1, pp. 240-248
Open Access | Times Cited: 15
Epigenetic interplays between DNA demethylation and histone methylation for protecting oncogenesis
Kanji Furuya, Masae Ikura, Tsuyoshi Ikura
The Journal of Biochemistry (2018) Vol. 165, Iss. 4, pp. 297-299
Open Access | Times Cited: 13
Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO–positive acute myeloid leukemia
Xi Yang, Chenglong Li, Rong Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 4
Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies
Eunyoung Lee, Youngil Koh, Junshik Hong, et al.
Journal of Korean Medical Science (2021) Vol. 36, Iss. 13
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top